Xiao-Long Liu

Xiao-Long Liu

Auto-generated profile, based on publicly available information

Xiao-Long Liu

Departments of Cardiology and Critical Care Medicine, The First Affiliated Hospital of Harbin Medical University, NHC Key Laboratory of Cell Transplantation, Key Laboratories of Education Ministry for Myocardial Ischemia Mechanism and Treatment, China (M.-M.W., Y.S., Y.Z., Y.-C.Y., Z.-X.H., S.Z., X.W., H.X., M.Y., C.M., B.-W.Z., X.-L.L., J.-Y.C., D.Z., Z.H., M.Z., H.-T.X., X.B., J.-J.M., J.S., C.L., Q.-S.W., J.Z., Y.L., Z.-R.Z.).

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 July 2022 in Stem Cells International
Verified
Journal Article
Open access
PDF file
XLXiaolong Liu
Xiaolong Liu
XLXuran Li
Xuran Li
GWGuangyuan Wu
Guangyuan Wu
PQPengfei Qi
Pengfei Qi
YZYanyan Zhang
Yanyan Zhang
HZhong zhang
hong zhang
Objective. Rapid restoration of corneal epithelium integrity after injury is particularly important for preserving corneal transparency and vision. Mesenchymal stem cells (MSCs) can be taken into account as the promising regenerative therapeutics for improvement of wound healing processes based on the variety of the effective components. The extracellular vesicles form MSCs, especially exosomes, have been considered as important paracrine mediators though transferring microRNAs into recipient cell. This study investigated the mechanism of human umbilical cord MSC-derived small extracellular vesicles (HUMSC-sEVs) on corneal epithelial wound healing. Methods. HUMSC-sEVs were identified by transmission electron microscopy, nanoparticle tracking analysis, and Western blot. Corneal fluorescein staining and histological staining were evaluated in a corneal mechanical wound model. Changes in HCEC proliferation after HUMSC-sEVs or miR-21 mimic treatment were evaluated by CCK-8 and EdU assays, while migration was assessed by in vitro scratch wound assay. Full-length transcriptome sequencing was performed to identify the differentially expressed genes associated with HUMSC-sEVs treatment, followed by validation via real-time PCR and Western blot. Results. The sEVs derived from HUMSCs can significantly promote corneal epithelial cell proliferation, migration in vitro, and corneal epithelial wound healing in vivo. Similar effects were obtained after miR-21 transfection, while the beneficial effects of HUMSC-sEVs were partially negated by miR-21 knockdown. Results also show that the benefits are associated with decreased PTEN level and activated the PI3K/Akt signaling pathway in HCECs. Conclusion. HUMSC-sEVs could enhance the recovery of corneal epithelial wounds though restraining PTEN by transferring miR-21 and may represent a promising novel therapeutic agent for corneal wound repair.

29 September 2026 in Circulation
Verified
Journal Article
Closed access
MWMing-Ming Wu
Ming-Ming Wu
YSYu Sun
Yu Sun
YZYue Zhang
Yue Zhang
YYYan-Chao Yang
Yan-Chao Yang
ZHZhi-Xi He
Zhi-Xi He
ZZZhi-Ren Zhang
Zhi-Ren Zhang
BACKGROUND: The use of anti–programmed cell death-1 (PD-1) antibody increases heart failure (HF) risk in patients with cancer with preexisting cardiovascular conditions. However, the underlying mechanism remains incompletely understood. METHODS: To evaluate the effects of anti–PD-1 antibody on transverse aortic constriction (TAC)–induced cardiac remodeling and HF, anti–PD-1 antibody–treated mice; T cell–, myeloid-, and CD8 + T cell–specific Pdcd1 knockout; C-X-C motif chemokine receptor 3 ( Cxcr3 ) knockout; and granzyme B ( Gzmb ) knockout mice combined with flow cytometry, Western blotting, immunofluorescence staining, pharmacological approaches, and bulk RNA-sequencing analyses were used. RESULTS: Administration of anti–PD-1 antibody, T cell–, or CD8 + T cell–specific Pdcd1 deletion, but not myeloid-specific Pdcd1 knockout, aggravated TAC-induced cardiomyopathy and HF in mice. Mechanistically, PD-1 blockade or deletion increased myocardial infiltration of CXCR3 + CD8 + T cells, leading to granzyme B/perforin–mediated impairment of cardiomyocyte mitochondrial complex I to exacerbate TAC-induced cardiac injury and HF. TAC-enhanced chemotaxis, between cardiac fibroblast–derived CXCL9/CXCL10 and CXCR3 + CD8 + T cells, was a driving force for recruiting CXCR3 + CD8 + T cells under the conditions of PD-1 blockade or deletion. The worsened TAC-induced cardiomyopathy caused by anti–PD-1 antibody or T cell–specific Pdcd1 deletion was rescued by genetic deletion or pharmacological blockade of granzyme B and CXCR3. CONCLUSIONS: Anti–PD-1 antibody enhances myocardial infiltration of CXCR3 + CD8 + T cells under TAC condition through CXCL9/CXCL10–mediated chemotaxis. The increased granzyme B and perforin likely derived from CD8 + T cells impair function of mitochondrial respiratory chain complexes to cause cardiomyocyte apoptosis, thereby exacerbating TAC-induced cardiomyopathy and HF. CXCL9/CXCL10-CXCR3 + CD8 + T cell axis may represent a promising target for combating anti–PD-1 antibody–associated cardiotoxicity.